-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Category Archives: Business and Investments
Latest From Business and Investments
To Cancel or Not to Cancel
That is the question! And one that is going to come up quite a bit as we get closer to the BIO International Convention, and so we wanted to address it. You learned all about the Scheduling Process in a previous post, such as what is a delegate’s responsibility, like updating your availability, and what BIO takes care of for you, such as assigning actual space to your meetings. On the note of availability, we Read More >
Tradeshow Speed Dating: Associations Now Piece
In the April/May issue of Associations Now, writer Jacqui Cook profiled the Biotechnology Industry Organization (BIO) and, appropriately for this post, the BIO One-on-One Partnering System. They give a good synopsis of some of the challenges organizations – and people – face at a typical tradeshow. You’re going there to make contacts, not to mention spending money to do so, and there’s often no real structure, process, or easy ways to discern the value of Read More >
Only a Few Public Biotechs are Profitable, but There are More of Them Today
Of the 294 biotechs trading on public exchanges today, 248 (84%) focus on drug development. Of these 248 in the biopharmaceutical space, 81, or 33% have a drug approved. Only 32 (13%) had both a product on the market and positive net income in 2011. However, this 13% represents a significant jump from the 7.5% with positive net income we calculated for 2009. Note that this comes over a time frame in which a few profitable companies were Read More >
The Scheduling Process
Scheduling for companies will kick into full gear the week of May 28th for the BIO Business Forum and participating exhibiting companies. As mentioned in a previous post, we wanted to discuss scheduling in a bit more detail, so that you understand what scheduling means, and how it impacts the way you use the Partnering System. First and foremost, meetings are only scheduled for those in Accepted/Agreed-To status. Your action item? Go in to your Read More >
Monday Items for #BIO2012 Business Forum
Happy Monday Everyone! We thought we would do a quick post on some important items concerning the BIO Business Forum and One-on-One Partnering. The Profile Publication Deadline is May 22nd. Why is this important? For one, if you have not published your profile, companies just have a harder time finding you. Make it easy for them. Fill out your keywords; provide as much detail in the assets/products/services categories as possible; Publish and Save! Second, publishing Read More >
